Clinical Pathological Comparison between African Americans and Caucasians

Association between a history of TBI and cognitive decline in subjects with
autopsy confirmed AD

The Relationships Among Body Mass Index, Alzheimer's Disease Neuropathology,
and Cerebrovascular Disease

White matter signal abnormalities in Alzheimer's disease

Longitudinal analysis of APOE and gender mediated conversion risk in
preclinical AD

Why do so many clinical trials for possible therapies for Alzheimer?s disease
fail?

Behavioral Reserve in MCI and AD

Sleep Disturbances in Cognitively Asymptomatic Patients with
Histopathologically Confirmed AD Predict Rapid Cognitive Deterioration

Subjective Memory Complaints in Cultural Majority and Minority Groups

Barriers to engagement in genetic research

Symptoms are associated with atrophy patterns in Alzheimer disease (AD).

Memory performance in ADC/NACC data

Neuropathological Agreement with the Clinical Diagnosis of Alzheimer's Disease

Description of the Uniform Data Set Database

The National Alzheimers Coordinating Centers Data Submissions System and
Database

Association of the frailty syndrome and risk of developing Alzheimer's disease

Supplementary Scores for the Uniform Data Set 3.0: Normative data and
exploration in clinical populations

Associations between cardiovascular disease and FTLD-TDP

Body Mass Index, Weight Change, and Clinical Progression in MCI and AD

Characterizing PD-MCI in the NACC sample

Clinical characteristics among asymptomatic PART subjects

Late life systolic blood pressure, body mass index, and heart rate, and
Alzheimers neuropathology among those without dementia before autopsy

The Impact of Latino Values and Cultural Beliefs on Brain Donation: Developing

Analytic Strategies for the NACC Database

Estimation of APOE risk curves for the Alzheimer Prevention Initiative

Small vessel disease and beta-amyloid deposition in mildly impaired cognition

Sleep Phenotypes by Diagnosis

The intersection of amyloid and cerebrovascular pathology: the perivascular
space

Medication Use in Frontotemporal Lobar Degeneration (FTLD) as compared to
Alzheimers Disease (AD)

Hearing and visual impairments and link to dementia

Prevalence of cerebral amyloid angiopathy in NACC NP dataset

Prevalence of mixed neuropathologies in autopsied older adults and associations

The associations of social relationships with risk of incident amnestic and

Cost-Benefit Analysis (CBA) of Years of Education as an intervention in
Alzheimer's Disease

Common Functional Deficits in MCI and Dementia

African-Americans and Alzheimer's Disease: Understanding the Risk Factors

Factors Influencing Attrition Over Time

Interactions between Behavioral Factors and APOE in predicting Alzheimer's
Disease

Sex differences in brain structures and progression to mild cognitive
impairment and probable Alzheimer?s disease development

longitudinal aspects of prescription drug usage during various stages of

Logical memory delayed recall, men vs. women

Causes and disease progression of dementia among Asians

A Brief Report on the Appropriateness of the MMSE score as an

Test the reliability of doubly robust estimation with missing response data

Use of empirical likelihood to calibrate auxiliary information in isotonic

Simulation study on the area under the ROC curve in the presence of missingness

Association of Lewy body pathology with UPDRS motor scores, Neuropsychiatric
symptoms, and Depression scores among persons with Neuropathological AD

Validation of the TICS and DQ for Dementia status in the Long Life Family Study

Genome-wide association study of neuropsychiatric symptoms in dementia

Modifier Genes that Influence Age at Onset or Protect Against Development of
Alzheimer's Disease (AD)

Relating NPI-Q Scores to the Pathologic Burden of AD Based on NACC Data

Reliability of Self-Reported Medical Histories in Older Adults With and Without

Studying the effect of white matter hyperintensities in different brain regions

Aging and Health among Older Adults with Traumatic Brain Injury

Assessing the impact of delays in onset of mild cognitive impairment on the

Embedded Performance Validity Tests in Normal Adults, Mild Cognitive

Alzheimer's Disease Transition Probabilities in the National Alzheimer's

APOE and age of Alzheimer's disease onset

JI award: Polygenetic risk score for AD

Clinical phenotype of dementia after traumatic brain injury (TBI).

Clinical characteristics of early-onset AD

Application of Big Data Analytical Approaches to NACC UDS data

Developing tractography algorithms for detecting abnormal structural brain
networks in Alzheimer's disease: Application to NACC data

ROC analysis of UDS neuropsychological tests

UDS 3 Norms

Relationship of cardiovascular risk factors to dementia subtypes

Anti-psychotic Dementia Study

Neuroimaging Correlates of Delusions in Alzheimer's Disease and Related
Dementias

Decision quality and the use of cardiac rhythm regulating devices in adults

Genetic, clinical and environmental factors and cognitive decline in AD

Late life depression and risk of Alzheimer???s dementia: A longitudinal
analysis to determine predictors of increased risk among non-demented older

Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians
with Alzheimer's Disease

Validation of non-amyloid, non-Tau CSF biomarkers for Alzheimer's disease

Diagnostic Patterns and Healthcare Resource Utilization in Patients with

Empirical Examination of Mismatched In-Vivo and Neuropathological Alzheimer's
Disease Diagnosis

A Clinical Taxometric Investigation of Alzheimer's Disease and Other Dementias

Cognitive aging trajectories in Alzheimers disease

Robust Norms

The influence of brain pathology, APOE genotype, and cognitive reserve on
longitudinal cognitive and functional decline.

Exploring the cognitive and motor predictors of finance and medication

Neuropathological correlates of mild cognitive impairment

Subjective Memory Complaint and Cognitive Aging

Rate of functional decline in AD, VaD and DLB

Stability of Dementia Diagnosis among UDS Participants

Impact of different blood pressure cutoffs on cognitive functioning and disease

Proton Pump Inhibitors and Risk for Mild Cognitive Impairment and Dementia

Differences in pathological substrate underlying dementia in African Americans
and Caucasians

Predictors of survival in Lewy body disease

Anticholinergic Burden Among Older Community-Dwelling Older Adults

Are eligible AD clinical trial participants more likely to have spousal
caregivers than adult children caregivers?

Assessing disease progression among Alzheimer's disease patients with adult
child study partners

Choosing Alzheimers disease prevention clinical trial populations.

Examining predictors of AD pathology among cognitively normal UDS participants

A reliable, standardized general cognitive performance measure in NACC

Body Mass index Change in Alzheimers Disease Patients

UPPGRAID: Understanding and Predicting Personalized Growth Rate curves to Aid
Individual prognosis in late-onset Dementia

Atrial Fibrillation in AD Patients

The Vascular Component of Behavioral Variant Frontotemporal Dementia

Antihypertensive effects on neuropathological findings: Analysis of data from

Associations between thyroid disease and neuropathologic changes in a large

Cholinesterase Inhibitor Use and Cognitive Decline in Mild Cognitive
Impairment and Mild Dementia due to Alzheimer Disease

Modelling the natural disease progression of Alzheimer's disease

Latent Class Analysis of MCI Using Longitudinal Clinical Features

Latent Structure of the Mild Cognitive Impairment Syndrome

Identification of Cognitive Endophenotypes

Comparing decade of life with APOE e2/3/4 status

Atherosclerosis and AD: analysis of data from the US National Alzheimer's
Coordinating Center

Non-homogeneous Markov process models for rate of conversion to MCI

APOEe2 is associated with milder clinical and pathological Alzheimer
disease

Clinical -Pathological investigation regarding new criteria for

Neuropathological Correlates of Progression

Impact of Cardiovascular Risk Factors on Cognitive Scores Over Time

Identification of endophenotypes in frontotemporal degeneration

Cognitive subtypes of probable Alzheimer?s disease

Sensitivity and specificity of the Multilingual Naming Test (MINT) in

Vascular risk factors of cognitive aging

CSF biomarkers and cognitive function in primary age-related tauopathy and
Alzheimer's dementia

Genetic risk factors of primary age related tauopathy

A Cross-Sectional and Longitudinal Comparison of Diagnostic Accuracy of the

Confirmatory Factor Analyses Using Neuropsychiatric Inventory Data
from the National Alzheimer's Coordinating Center

Clinicopathologic correlation in FTLD

Trajectory of Dementia

APOE and Relationship to Abstinence from Cigarette Smoking among Older Adults
with Normal Cognition

Characterizing Substance Use History in Frontotemporal Dementia

Measuring memory performance using the Montreal Cognitive Assessment and the

United Parkinson's Disease Rating Scale (UPDRS) Data Analyses

Enhancing Medication Management Through the Use of Clinical Decision Support
Software Platforms

Exploring Biologically-Informed Models of Alzheimer's Disease

Investigation of Gait Changes in Subjective Cognitive Decline

Towards a Unified Language of Cognition: Defining Domains, Normality, and
Change

The utility of a language domain rating and a behavior-comportment and

Characterizing UDS Participants who Revert from MCI to Normal Cognition

Education, cognitive function, and severity of neuropathology in AD

Validating Neuroimaging-driven deep learning models using PET and CSF
biomarkers

Observation of neuropsychiatric Symptoms across Dementia Syndromes

Utility of the Clinical Dementia Rating Scale Sum of Boxes Scores in Staging
Dementia Severity

Applying 'growth curves' to age-associated cognitive decline: an innovative
method to help determine normal vs. abnormal longitudinal cognitive changes in

Test performance indicators

Novel magnetic resonance imaging (MRI) based biomarkers for cerebrovascular

Inappropriate Drug Use among Community-Dwelling Elders with Dementia

'Phase II and III trial simulators: Using mathematical, computational and
statistical techniques to simulate trial design for new products in the

Pathological-Behavioral correlations in FTD spectrum disorders

Latent Classes of Cognitive and Functional Trajectories in AD

Mild behavioral impairment (MBI) in normal aging and MCI

Distribution and Correlation of AD survival andprogression rates with
Neuropathology

Factors Associated with Use of Memantine

Functional Ability Change Trajectory Simulation for Cognitive Decline Patients:

Comparing the effects of subjective cognitive decline and neuropsychiatric
symptoms on neurocognitive disorders

Identifying the optimal short version of Montreal Cognitive Assessments

Traumatic Brain Injury in Early versus Late Onset Alzheimer's Disease

Alzheimer's Disease in Under-represented Populations

Covariate adjustment in estimating the area under the ROC curve with partially

Estimating the standardized ROC curve adjusting for covariate effects with

Behavioral, Neurocognitive, and Neuroimaging Markers Associated with
Autopsy-recognized AD, FTD, and CTE

Risk of Self-Reported Head Injury in the Development of Mild Cognitive
Impairment and Alzheimer's Disease

Traumatic Brain Injury History and Progression from Mild Cognitive Impairment

Traumatic Brain Injury History and Risk of Alzheimer's Disease, Lewy Body

Associations between microinfarcts and other macroscopic vascular findings on

Normative data for the neuropsychological assessment from the Alzheimers

Clinically Unrecognized Cases of Prion Disease in the National Alzheimer's

Understanding the preferential relationships between the cardinal pathologies
of Alzheimer?s disease and different aspects of the clinical phenotype

Mild Cognitive Impairment in Older, Rural Dwelling Adults

Determinants of Judgment and Problem Solving

Ethnic Differences in Alzheimer's Disease Survival and Pathology

A liability model to increase power in genome-wide association

Dysexecutive function in Alzheimer's Disease: A genetic and neuropsychologic

Heritability for dysexecutive function

Longitudinal evaluation of dysexecutive vs. amnestic Alzheimer's

Risk of progression from incident MCI

The association between weight change, cognitive, functional, and behavioral

The relationship between neuropathology and expression of dementia in the

Screening for Mild Cognitive Impairment and Alzheimer?s Disease among Minority
Populations using the Montreal Cognitive Assessment

Identifying functional milestones in disease progression in frontotemporal
dementia

Heterogeneity of Informant-Reported Functional Impairments in Older Adults

: Comparison of symptomatic and asymptomatic persons with underlying Alzheimers

Genetic differences between symptomatic and asymptomatic persons with AD
neuropathologic change

Trends in performance on neuropsychological tests for asymptomatic persons with

An investigation of the impact of neurocognitive disorders on women

Evaluating the magnitude of potentially inappropriate medication prescribing
and its impact on mortality in the NACC cohort

Evaluation of use and risks associated with bladder antimuscarinics

APOE e4 and clinical progression in Parkinson's disease

NACC Uniform Data Set Neuropsychological Battery Crosswalk Study

Variation among different measurements of cognitive decline

The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive

Factors Influencing Lumbar Puncture Participation in Alzheimer Research

Impact of education and vascular injuries on development of dementia

Pathology of Rapid Cognitive Decline

Basic clinical-pathological correlation in AD

Braak Staging over Time: A Possible Cohort Effect

Clinicopathological correlation in Dementia with Lewy bodies (DLB)

Evaluating genetic risk factors of hippocampal sclerosis (HS) in FTLD

Evaluation of association between sulfonylurea use and hippocampal sclerosis
pathology

Hippocampal sclerosis of aging in NACC

Primary age-related tauopathy (PART): a common pathology associated with human
aging

The NP version 10 form

Analysis of APOE Genotypes and Cognitive Status in the Global Alzheimer's
Association Interactive Network

The role of executive function and functional decline in conversion from normal

Diagnostic Accuracy of the MMSE in Detecting Dementia in Ethnically Diverse
Highly Educated Individuals

Effects of 100 commonly used drugs on cognitive performance in older adults.

Patterns and predictors of long-term opioid use in the NACC cohort

Base rate of low scores in neuropsychological testing

Prevalence of amyloid pathology in demented patients

Shape Analysis of Hippocampi between APOE e2 Carriers and Non-Carriers

Comparison of dementia, MCI and mental health status between older adults with
same sex partners and opposite sex partners

Risk of dementia and mild cognitive impairment among older adults of different
racial and ethnic minorities

Description of UDS MCI, pre-MCI, and Control Subjects

Neuropsychological predictors of dementia progression trajectory

Speed of Quartile of survival times in AD subjects after death

Variability in clinical trajectory within AD, FTD, LBD, VD, HSD, CJD and mixed
dementia diagnostic categories.

Non-replication of an association of Apolipoprotein E2 with sinistrality

CSF in AD and TBI

(1) Neuromorphometric longitudinal normative data and (2) Neuromorphometric
profiles of neuropathological characteristics: an update

The Unique Contribution of White Matter Hyperintensities to Cognitive,
Neuropsychiatric, and Functional Decline in Alzheimer's Disease

Neuroimaging Correlates of Delusions in Alzheimer's Disease and Related
Dementias

Transformation model estimation of survival under dependent truncation and

ACE Inhibitor, Angiotensin II Receptor Blockers, and ApoE4 on Alzheimer's

Identifying factors that substantially impact AD or dementia progression

Neuropathological Changes in Dementia in Patients with Co-morbid Depression

Neuropathological assessments of fibrillar amyloid burden in APOE e4 carriers
and non-carriers with the clinical diagnosis of Alzheimer's dementia

Interaction between APOE and life risk factors on dementia

Clinical and Cognitive Predictors of Severe Cerebral Amyloid Angiopathy

Demographic, genetic, and pathological correlates of Cerebral Amyloid
Angiopathy

CSF Biomarkers of AD: Cognitive and Non-Cognitive Outcomes

Comparison between clinical-pathological phenotype between dominantly-inherited

Education, The Cognitive Reserve Hypothesis, and Alzheimer's Disease Without
Dementia

Level of functional and cognitive impairment as a function of DAT severity

Sex-specific patterns and differences in the core modalities associated with
Alzheimer's disease

Affective symptoms and vascular factors are more prevalent in non-amnestic
than amnestic Mild Cognitive Impairment (MCI)

The association of neuropsychiatric symptoms in MCI with incident dementia and
Alzheimers Disease.

AD Neuropathology in those with APOE e2/e2 alleles

The effect of statins on the neuropathology of dementia due to Alzheimer's

Assessing the effect of race and education on the

EXPLORING MULTIDIMENSIONAL COMPLEXITY IN THE DEMENTIAS: THE ASSOCIATION OF

Diabetes and Alzheimers Disease in the Uniform Data Set

Cross-cultural Differences in the Diagnosis of Dementia

TBI and Age of Dementia Diagnosis in an Autopsy-Confirmed Sample

Evaluating the contribution of Thal stages to cognitive impairment due to
Alzheimer disease

Clinicopathologic correlation: Alzheimer mimics

The effects of APOE genotype on cognitive function

Normative Calculator for the Uniform Data Set (UDS) Neuropsychological Test

Association of Cognitive Impairment and Depression

Investigating the impact of diabetes on depression and on the relationship
between depression and cognition

Evaluating whole brain health using Brain Atrophy and Lesion Index:
validation using large datasets

Dependence as a health outcome for Alzheimer's disease

Transitions and pharmaceutical use by CDR level in Alzheimers disease.

The Placebo Group Simulation Approach (PGSA): Predicting Decline in Patients

Comparison of standardized and non-standardized administration of WMS Logical
Memory Delayed in a population of older adults with probable Alzheimers

Hypertension and the effect of hypertension on cognitive decline using NACC UDS

Noradrenergic Medications and Progression of MCI

Statins and cognitive changes over time

The effect of anti-hypertensive medication acting on the rennin-angiotensin
system on cognitive function

Variations across Centers

The relationship between interval changes in neuropsychiatric symptoms and a
diagnosis of mild cognitive impairment

Anticholinergic Drug Use And Risk Of Cognitive Decline And Dementia Among Older

Correlates of Psychosis in AD

Genetics of psychosis in AD

Determining specific functional declines associated with progression from mild

Investigating the Role of Traumatic Brain Injury as a Risk Factor for
Frontotemporal Lobar Degeneration

Patterns of Functional Decline in Clinical Subtypes of Frontotemporal Dementia

Utility of the Functional Activities Questionnaire in Distinguishing Between
Mild Cognitive Impairment and Mild Alzheimer's Disease

Neuropathology of Depression in MCI and Early AD

Anatomical Correlation of Phonological Dyslexia in Primary Progressive Aphasia
(PPA)

Clinicopathological correlation of psychosis and brain vascular burden in
Alzheimer's disease

Cerebrovascular changes and prevalence of vascular risk factors across
different neurodegenerative diseases

Categorical factor analysis of the Unified Parkinson's Disease Rating scale in
Alzheimer's Disease

Effect of TBI on cognition and its decline

Specifically, we propose to apply a longitudinal factor analysis model to a
variety of neuropsychological tests and estimate a smooth cognitive trajectory.

Comparison of Agitation and Aggression Across Dementias: Relationship to

Does white matter degeneration occur early in the progress of Alzheimer's

Association of cardiovascular health and vascular neuropathology findings

Role of Vascular Risk factors on progression of cognitive impairment in AD

Clinical, biomarker and genetic correlations in autosomal dominant
Alzheimer?s disease (ADAD) and neuropathologically confirmed late onset

Latent Structure of Alzheimer's Disease: A Taxometric Analysis of
Neuropsychological Indicators

Causal inference with truncation by death in observational study

Diagnosis independent assessment of predictive ability of MRI biomarkers for AD

Age at onset, education and MMSE in Native Americans

Describe score distributions for Normal, MCI, and specific dementia diagnoses.

Racial differences on neuropsychological test performance

Evaluation of Cerebrospinal Fluid Assay Variability

Autosomal recessive causes of early onset Alzheimer's disease

Estimate the heritability of AD using family history data

Characterizing MCI subjects who remained cognitively stable

Predicting trajectories of MCI with medical, demographic, genetic, and
neuropsychological data

Clinical utility of the Clinical Dementia Rating Scale for Parkinson's
disease dementia

Antedependence Models for Nonstationary Categorical Longitudinal Data with
Ignorable Missingness: Likelihood-Based Inference

Longitudinal trajectory of neuropsychological performance and dementia subtypes

HLA genotypes and risk for AD

Estimation of AUC through propensity-score-adjustment approach under
non-ignorable verification bias

Joint random-effects transition models for multivariate longitudinal data

Modeling Disease Progression in Alzheimer's and Parkinson's disease

The association between benzodiazepine (BZD) use and dementia and/or cognitive
impairment using NACC data

Analysis of binary long data in multi-center studies with missing covariates

Applied Missing Data Analysis in Health Sciences

Estimate the ROC curve and its area in the presence of nonignorable
verification bias